Altimmune ALT Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Altimmune in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Altimmune's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Altimmune's total current liabilities?
- Altimmune (ALT) reported total current liabilities of $11.32M in Q1 2026.
- How has Altimmune's total current liabilities changed year-over-year?
- Altimmune's total current liabilities increased by 15.6% year-over-year, from $9.8M to $11.32M.
- What is the long-term trend for Altimmune's total current liabilities?
- Over 5 years (2020 to 2025), Altimmune's total current liabilities has grown at a 4.5% compound annual growth rate (CAGR), from $12.02M to $15M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.